WDR5 and breast cancer: In their present work, Punzi and colleagues report that downregulation of WDR5 by shRNA in breast cancer cells antagonizes the epithelial-to-mesenchymal transition through re-differentiation and reduces metastasis in a mouse model (Punzi et al., 2019[17]).